ArticleMolecular pharmacology2015

Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity.

David E Durrant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.